Netherlands · 
Who invested in Flindr Therapeutics?
Flindr Therapeutics's investors include BOM and Qbic Fund.
Netherlands · Series A startup
Who invested in Flindr Therapeutics
Funding summaryUpdated 26 Oct 2026
$21Mraised across 1 round since 2024, from 1 source
- Latest round
- Series A, $21MApr 2024
- Investors
- 2
The rounds
- Apr 2024
Founders and team
From Flindr Therapeutics's own website: 3 founders, 11 on the team.
Maarten LigtenbergFounder / Chief Executive Officer
Christian BlankFounder
Daniel PeeperFounder / SAB Chairman
- Erica HouthuysChief Scientific Officer
- Jac WijkmansChief Technology Officer
- Sally RossChief Development Officer
- Bernard CouliChairman
- Chris de JongheBoard Member
- Christina TakkeBoard Member
- Cédric Van NevelBoard Member
- Fiona MacLaughlinBoard Member
- Gary B. GordonBoard Member
- Simon SturgeBoard Member
- Tine BekaertBoard Member
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Flindr Therapeutics
How much has Flindr Therapeutics raised?
Flindr Therapeutics has raised $21M across 1 round since 2024.
When did Flindr Therapeutics last raise?
Flindr Therapeutics's most recent round was a Series A of $21M in Apr 2024.
What was Flindr Therapeutics's biggest round?
Its most recent round, $21M in Apr 2024, is also its largest on record.
Who backed Flindr Therapeutics first?
Flindr Therapeutics's first round on record, in Apr 2024, was backed by BOM and Qbic Fund.
What stage is Flindr Therapeutics at?
Flindr Therapeutics's latest named round is a Series A, in Apr 2024.
Where is Flindr Therapeutics based?
Flindr Therapeutics is based in the Netherlands.
Companies like Flindr Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.